GlassScriptPhysician profile
Dennis Vanloozen
NPI 1629417555
$3,513.52
in general payments reported to CMS, 2019-2025
11 companies · $89.84 in 2025
The $89.84 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $21.32 · 2021: $317 · 2022: $1,680 · 2023: $1,133 · 2024: $132 · 2025: $89.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051 · Travel and Lodging: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.71 |
| Travel and Lodging | $303.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,932.42 | 2021-2025 | Concertotm, Harmony, Mvp |
| Edwards Lifesciences Corporation | $821.27 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $244.92 | 2021-2024 | Amplatzer Amulet, Amplatzer, Amplatzer Piccolo |
| Numed For Children, LLC | $157.43 | 2021 | |
| Medtronic Vascular, INC. | $142.70 | 2019-2020 | |
| Penumbra, INC. | $78.29 | 2022 | |
| Biosense Webster, INC. | $40.47 | 2024 | Carto 3 |
| Terumo Medical Corporation | $28.71 | 2023 | Glidesheath Slender, Navicross |
| W. L. Gore & Associates, INC. | $25.37 | 2024 | Gore Cardioform Septal Occluder |
| Pacira Pharmaceuticals Incorporated | $23.10 | 2024 | Exparel |
| Mallinckrodt Enterprises LLC | $18.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Vanloozen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.